Posts Tagged Wilmot Cancer Institute

Chemo-brain, or cancer-related cognitive impairment, is estimated to impact 80 percent of people in treatment. A new Medical Center study shows that inflammation in the blood plays a key role.

UR Medicine’s Wilmot Cancer Institute will be among the first sites in the world to offer CAR T-cell therapy —a new type of immunotherapy approved this week by the FDA—to adults with aggressive lymphoma. The engineered gene therapy has been described as a revolutionary “living drug” and one of the most powerful cancer treatments to emerge in recent years.

A new $3 million grant to the Wilmot Cancer Institute allows oncologists to evaluate whether adding vitamin D to standard therapy will help cancer patients live longer.

Researchers from the Center for RNA Biology have identified a new way to potentially slow the fast-growing cells that characterize all types of cancer.

The science behind harnessing the immune system to fight cancer is complicated, but a Medical Center laboratory discovered a simple, practical way to use light and optics to steer killer immune cells toward tumors.

Exercise or psychological therapy work better than medications to reduce cancer-related fatigue and should be recommended first to patients, according to a Wilmot Cancer Institute–led study published in JAMA Oncology.

The largest study to date of memory and cognition problems related to chemotherapy shows that women with breast cancer report substantial issues lasting as long as six months after treatment.

Researchers at the University’s Wilmot Cancer Institute and Roswell Park in Buffalo have discovered a possible new tool for predicting whether prostate cancer will reoccur following surgery based on the expression patterns of four genes.

Wilmot Cancer Institute discovered something simple and inexpensive to reduce pain and tingling in hands and feet due to chemotherapy—exercise.

The results of an Wilmot Cancer Institute clinical trial for pancreatic cancer show that an experimental drug, coupled with chemotherapy, can control tumors well enough to make some patients eligible for surgery.